Akhter Nausheen, Milford-Beland Sarah, Roe Matthew T, Piana Robert N, Kao John, Shroff Adhir
Division of Cardiology, University of Illinois at Chicago Medical Center, Chicago, IL 60612, USA.
Am Heart J. 2009 Jan;157(1):141-8. doi: 10.1016/j.ahj.2008.08.012.
Although prior studies have demonstrated disparities in the management and outcomes of women with acute coronary syndrome (ACS), there are limited large-scale contemporary data on gender differences in post-intervention outcomes in this population.
We analyzed patients according to 2 ACS categories, unstable angina/non-ST-elevation myocardial infarction (UA/NSTEMI) and ST-elevation myocardial infarction (STEMI) who had a percutaneous coronary intervention in the ACC-NCDR from January 1, 2004, to March 30, 2006. Of 199,690 patients, 55,691 women presented with UA/NSTEMI, and 12,335 women presented with STEMI. Clinical and angiographic characteristics, procedural and treatment patterns, and in-hospital outcomes were examined.
Women presented more often with UA/NSTEMI than men (82% of women vs 77% of men, P < .0001). Despite having greater comorbidities, women in both ACS categories had fewer high risk angiographic features than men. Women were less likely to receive aspirin or glycoprotein IIb/IIIa inhibitors, and were less often discharged on aspirin or statin. For in-hospital mortality, the adjusted odds ratio for men compared to women was similar (odds ratio 0.97, P = .5). Women had higher rates of cardiogenic shock, congestive heart failure, any bleeding, and any vascular complications. Importantly, rates of subacute stent thrombosis were less in women compared to men (0.43% vs 0.57%, P = .0003).
Although women had fewer high-risk angiographic features than men, they continue to have higher rates of in-hospital complications. This suggests the need for gender-tailored techniques to minimize post-intervention complications and maximize application of evidence-based antiplatelet therapies.
尽管先前的研究已经证明急性冠状动脉综合征(ACS)女性患者在治疗管理和预后方面存在差异,但关于该人群干预后结局的性别差异,大规模的当代数据有限。
我们根据2种ACS类别分析患者,即不稳定型心绞痛/非ST段抬高型心肌梗死(UA/NSTEMI)和ST段抬高型心肌梗死(STEMI),这些患者于2004年1月1日至2006年3月30日在ACC-NCDR接受了经皮冠状动脉介入治疗。在199,690例患者中,55,691例女性表现为UA/NSTEMI,12,335例女性表现为STEMI。我们检查了临床和血管造影特征、手术和治疗模式以及住院结局。
女性比男性更常表现为UA/NSTEMI(女性为82%,男性为77%,P <.0001)。尽管合并症更多,但两类ACS女性患者的高危血管造影特征均少于男性。女性接受阿司匹林或糖蛋白IIb/IIIa抑制剂的可能性较小,出院时服用阿司匹林或他汀类药物的情况也较少。对于住院死亡率,男性与女性相比的调整后比值比相似(比值比0.97,P =.5)。女性的心源性休克、充血性心力衰竭、任何出血和任何血管并发症的发生率更高。重要的是,与男性相比,女性亚急性支架血栓形成的发生率较低(0.43%对0.57%,P =.0003)。
尽管女性的高危血管造影特征少于男性,但她们的住院并发症发生率仍然较高。这表明需要采用针对性别的技术,以尽量减少干预后并发症,并最大限度地应用基于证据的抗血小板治疗。